The Centre recently directed states and Union Territories to strictly enforce a ban on the reuse of single-use medical devices and disposable surgical items in public and private healthcare facilities, citing infection risks and instances of patients being charged the full cost of reused equipment.
Devices reportedly being reused include cardiac catheters, guidewires, balloon and ablation catheters, introducer sheaths, dialysis equipment such as dialysers and blood tubing, surgical staplers, laparoscopic trocars and orthopaedic drill bits. Syringes and needles have also been identified among items being reused. Single-use medical devices are designed to be used once and then discarded safely. However, reports of their reuse in healthcare facilities have raised serious concerns about infection control, medical ethics and the accountability of hospitals. Items reportedly being reused include cardiac catheters, guidewires, balloon and ablation catheters, dialysis equipment, surgical staplers, laparoscopic trocars and orthopaedic drill bits. The reuse of syringes and needles is particularly alarming because it can directly expose patients to dangerous blood-borne infections. The risks associated with such practices cannot be underestimated. Improperly reprocessed medical equipment may carry blood, microorganisms and other infectious material from one patient to another. This can lead to serious complications, prolonged hospitalisation and, in severe cases, life-threatening infections. Patients undergoing cardiac procedures, dialysis and major surgeries are often already vulnerable. Exposing them to additional risks through unsafe practices amounts to a grave failure of the healthcare system. Equally disturbing are reports that patients have sometimes been charged the full price of medical equipment even when the items were reused. If established, such practices represent not merely a violation of safety norms but also an exploitation of patients who depend on hospitals during moments of extreme distress. Healthcare must be guided by compassion, transparency and professional responsibility, rather than commercial considerations at the expense of human lives. The Centre’s directive must therefore translate into effective action on the ground. State health departments, drug control authorities and hospital administrations should ensure regular inspections of public and private healthcare institutions. |
